Outcomes in Nontransfusion-Dependent β-Thalassemia Wit

Researchers determined luspatercept may improve outcomes in patients with nontransfusion-dependent β-thalassemia.

Related Keywords

Athens , Attikír , Greece , United States , American , Antonis Kattamis , American Society Of Hematology , Item Short Form Health Survey , University Of Athens , American Society , Annual Meeting , Reported Outcomes , Component Summary , Patient Global Impression ,